P

Inventor

ROTH BRUCE D

US36 patents
⚠️ This page may combine multiple inventors who share the name “ROTH BRUCE D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WARNER LAMBERT CO

35 patents
US5273995ADec 28, 1993

[R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]- 1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof

WARNER LAMBERT CO1,008 citations99
US4681893AJul 21, 1987

Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO672 citations99
US5324483AJun 28, 1994

Apparatus for multiple simultaneous synthesis

WARNER LAMBERT CO400 citations98
US5280126AJan 18, 1994

Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO134 citations98
US5245047ASep 14, 1993

Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO136 citations98
US5216174AJun 1, 1993

Process for trans-6-[12-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO163 citations98
US5149837ASep 22, 1992

Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO154 citations98
US5124482AJun 23, 1992

Process for trans-6-(2-substituted-pyrrol-1-yl)alkyl)pyran-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO174 citations98
US5097045AMar 17, 1992

Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO166 citations98
US5003080AMar 26, 1991

Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO240 citations98
US4647576AMar 3, 1987

Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis

WARNER LAMBERT CO299 citations97
US5015644AMay 14, 1991

Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds

WARNER LAMBERT CO77 citations96
US5612002AMar 18, 1997

Apparatus and method for multiple simultaneous synthesis

WARNER LAMBERT CO59 citations95
US4906624AMar 6, 1990

6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO62 citations95
US5385929AJan 31, 1995

[(Hydroxyphenylamino) carbonyl] pyrroles

WARNER LAMBERT CO301 citations93
US4957940ASep 18, 1990

Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis

WARNER LAMBERT CO41 citations93
US4906657AMar 6, 1990

Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis

WARNER LAMBERT CO47 citations93
US4735958AApr 5, 1988

Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO33 citations93
US5366987ANov 22, 1994

Isoxazolyl-substituted alkyl amide ACAT inhibitors

WARNER LAMBERT CO22 citations92
US5102893AApr 7, 1992

Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO23 citations92
US4997837AMar 5, 1991

6-(((substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO52 citations92
US4957971ASep 18, 1990

Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO24 citations92
US4929620AMay 29, 1990

5-pyrimidinyl-3,5-dihydroxy-6-heptenoic acid compounds useful as inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO50 citations92
US4761419AAug 2, 1988

6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO33 citations92
US4716175ADec 29, 1987

Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase

WARNER LAMBERT CO43 citations92
US5593967AJan 14, 1997

Cholecystokinin antagonists, their preparation and therapeutic use

WARNER LAMBERT CO22 citations91
US5489611AFeb 6, 1996

Method for lowering plasma levels of lipoprotein (a)

WARNER LAMBERT CO36 citations90
US5331006AJul 19, 1994

Amino acid analogs as CCK antagonists

WARNER LAMBERT CO21 citations90
US4808621AFeb 28, 1989

Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO16 citations74
US5441975AAug 15, 1995

Pyrazolo-substituted alkyl amide acat inhibitors

WARNER LAMBERT CO8 citations73
US5278326AJan 11, 1994

Substituted beta-ketoamide ACAT inhibitors

WARNER LAMBERT CO8 citations73
US5254589AOct 19, 1993

Sulfonyl urea and carbamate ACAT inhibitors

WARNER LAMBERT CO7 citations73
US4868185ASep 19, 1989

6-[[Substituted)pyrimidinyl)ethyl]- and ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

WARNER LAMBERT CO18 citations73
US4751229AJun 14, 1988

Treating fungal infections with substituted-(6-(tetrahydro-4-hydroxy-2-oxo-2H-pyran-2-yl)ethyl)- or ethenyl)pyrazoles

WARNER LAMBERT CO8 citations73
US4743605AMay 10, 1988

Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase

WARNER LAMBERT CO5 citations62

MILLENNIUM PHARM INC

1 patent